GMWatch mythbuster exposes UK government misinformation on gene editing
By GMWatch Staff,
GMWatch
| 02. 16. 2021
UK farm and environment ministry DEFRA published an “Explainer” document on gene editing as a guide for members of the public who want to respond to the UK government’s consultation on its plan to deregulate gene editing. It may also have been meant to assist the media, as parts of the text also occur in DEFRA’s press release for the launch of the public consultation.
Just over three weeks into the consultation the “Explainer” suddenly seemed to disappear from DEFRA’s website, possibly as a result of complaints.
There is certainly plenty to complain about. The “Explainer” is packed full of false assertions and reads like a “wish list” for the GMO lobby, presenting hypothetical “benefits” of gene editing as fact. The Cabinet Office Consultation Principles stipulate that “Consultations should be informative. Give enough information to ensure that those consulted understand the issues and can give informed responses”. They should “include validated impact assessments of the costs and benefits of the options being considered when possible".
But the information presented in the "Explainer" is extremely biased and only presents one side...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...